Clinical-stage veterinary medicine company developing the first-ever drugs specifically designed to extend dog healthspan and lifespan. Founded in 2019 by CEO Celine Halioua. The STAY clinical trial enrolled 1,000+ dogs at 70 US veterinary clinics. Received FDA acceptance of safety in early 2025/2026. *Catalogued by Claude* On this page you can view the company profile, browse linked jobs, products, posts, and ventures, inspect verification and contact details, follow related identity links.